semaglutide pdf Efficacy and safety of oral by subgroups of patient characteristics in the PIONEER phase 3 programme ECO 2026 - Gastrointestinal Tolerability

Surgeons should consider how the timing of elective procedures might shift if GLP-1 therapy is inducing substantial weight loss or anatomical change, which is relevant for bariatric, abdominal or head and neck surgeries

Akerman Augusto, J

These results held true regardless of baseline metabolic health, suggesting the medication works across different patient populations

This guide breaks down what half-life means in practical terms, how it affects semaglutides duration of action, why this specific half-life makes the medication so effective, and what it means for your day-to-day experience on treatment

Semaglutide for weight loss is generally indicated for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related comorbidity